Risk factors for de novo hepatitis B virus reactivation in liver transplant recipient with long term HBIG treatment

被引：0
|
作者：
Umeda, Makoto
Marusawa, Hiroyuki
Ueda, Mikiko
Tanaka, Yuichi
Takada, Yasutsugu
Egawa, Hiroto
Uemoto, Shinji
Chiba, Tsutomu
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A787 / A787
页数：1
相关论文
共 50 条
  • [1] Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
    Inada, Kento
    Kaneko, Shun
    Kurosaki, Masayuki
    Yamashita, Koji
    Kirino, Sakura
    Osawa, Leona
    Hayakawa, Yuka
    Sekiguchi, Shuhei
    Higuchi, Mayu
    Takaura, Kenta
    Maeyashiki, Chiaki
    Tamaki, Nobuharu
    Yasui, Yutaka
    Itakura, Jun
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Okamoto, Ryuichi
    Izumi, Namiki
    JGH OPEN, 2021, 5 (09): : 1085 - 1091
  • [2] Beneficial effects of short-term lamivudine treatment for de novo hepatitis B virus reactivation after liver transplantation
    Umeda, M.
    Marusawa, H.
    Ueda, M.
    Takada, Y.
    Egawa, H.
    Uemoto, S.
    Chiba, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (11) : 2680 - 2685
  • [3] Beneficial effects of short-term lamivudine treatment for de novo hepatitis B virus reactivation after liver transplantation
    Umeda, Makoto
    Marusawa, Hiroyuki
    Ueda, Yoshihide
    Ueda, Mikiko
    Takada, Yasutsugu
    Egawa, Hiroto
    Uemoto, Shinji
    Chiba, Tsutomu
    GASTROENTEROLOGY, 2007, 132 (04) : A755 - A755
  • [4] Combined short-term hepatitis B immunoglobulin (HBIG) and long-term lamivudine (LAM) versus HBIG monotherapy as hepatitis B virus (HBV) prophylaxis in liver transplant recipients
    Terrault, NA
    Wright, TL
    Roberts, JP
    Ascher, NL
    HEPATOLOGY, 1998, 28 (04) : 389A - 389A
  • [5] Ribavirin long-term treatment for chronic hepatitis E virus infection in a liver transplant recipient
    Casper, M.
    Reichert, M. C.
    Rissland, J.
    Gruenhage, F.
    Lammert, F.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (08) : 926 - 927
  • [6] Reactivation of occult hepatitis B virus infection in a renal transplant recipient
    Jiang, Lili
    Wang, Huiqi
    Huang, Yaping
    Liang, Hanying
    Wang, Xiaodong
    Fan, Jun
    VIROLOGY JOURNAL, 2022, 19 (01)
  • [7] Reactivation of occult hepatitis B virus infection in a renal transplant recipient
    Lili Jiang
    Huiqi Wang
    Yaping Huang
    Hanying Liang
    Xiaodong Wang
    Jun Fan
    Virology Journal, 19
  • [8] De novo hepatitis B due to vaccine-escape mutants in a liver transplant recipient
    Molina Rueda, Maria Jose
    Jimenez Romano, Elena
    Fernandez Sierra, Maria Amelia
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (08): : 546 - 547
  • [9] Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft
    Loreno, M
    Bo, P
    Senzolo, M
    Cillo, U
    Naoumov, N
    Burra, P
    TRANSPLANT INTERNATIONAL, 2004, 17 (11) : 730 - 734
  • [10] Treatment of hepatitis C virus in the liver transplant recipient
    Lafaine Grant
    Jeffrey S. Crippin
    Current Treatment Options in Gastroenterology, 2003, 6 (6) : 517 - 522
12345